Tezacaftor
Olfactory Nerve Disorder
University of California, Los AngelesSmall moleculeUnknownActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Olfactory Nerve Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Gonadorelin Nelly Pitteloud | Phase 2/3 | B |
Gnrh Nelly Pitteloud | Phase 2/3 | B |
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION Nelly Pitteloud | Phase 2/3 | B |
ELEXACAFTOR University of California, Los Angeles | Unknown | D |
Ivacaftor University of California, Los Angeles | Unknown | D |
Cyr-064 University of Nebraska | Phase 1 | NR |
Same molecule, other indications
Tezacaftor is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →